We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
-44.14%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$85.9M
AUM Growth
-$64.2M
Cap. Flow
+$3.16M
Cap. Flow %
3.68%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
IPSC icon
Century Therapeutics
IPSC
+$3.16M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$386M
$74.3M 86.51%
21,346,829
– –
ACHL
2
DELISTED
Achilles Therapeutics
ACHL
$9.04M 10.52%
11,086,909
– –
IPSC icon
3
Century Therapeutics
IPSC
$381M
$2.55M 2.97%
+1,000,771
New +$3.16M

Similar funds

BAM
BTS Asset Management Lincoln, Massachusetts $25.9M AUM 2.16% 1-Year Est. Return
FCC
Florin Court Capital London, United Kingdom $26.5M AUM 34.2% 1-Year Est. Return
BWG
Berry Wealth Group Granbury, Texas $26.8M AUM 31.56% 1-Year Est. Return
LTM
Lotus Technology Management Orlando, Florida $27M AUM
TCM
Teza Capital Management Chicago, Illinois $27.3M AUM 29.09% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
BCM
Bancreek Capital Management Santa Monica, California $23.1M AUM 4.01% 1-Year Est. Return
BCM
BCK Capital Management Stamford, Connecticut $23M AUM 33.03% 1-Year Est. Return

Syncona Portfolio's Q2 2024 Portfolio in Review

As of Q2 2024, Syncona Portfolio held 3 positions worth $85.9M, down 43% from $150M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Syncona Portfolio deployed $3.16M of net new capital in Q2 2024, opening 1 new position. Its largest new stake was Century Therapeutics: 1,000,771 shares worth $2.55M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio's largest Q2 2024 buy was Century Therapeutics: 1,000,771 shares worth $2.55M.
  • Syncona Portfolio's ten largest holdings make up 100% of its $85.9M portfolio in Q2 2024.
  • Syncona Portfolio opened 1 new position and closed 0 in Q2 2024.
  • Syncona Portfolio's portfolio value fell 43% quarter-over-quarter to $85.9M.

Based on Syncona Portfolio's 13F filing for Q2 2024, filed 13 Aug 2024.